Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Breast cancer: a candidate gene approach across the estrogen metabolic pathway.
Justenhoven C, Hamann U, Schubert F, Zapatka M, Pierl CB, Rabstein S, Selinski S, Mueller T, Ickstadt K, Gilbert M, Ko YD, Baisch C, Pesch B, Harth V, Bolt HM, Vollmert C, Illig T, Eils R, Dippon J, Brauch H. Justenhoven C, et al. Among authors: pierl cb. Breast Cancer Res Treat. 2008 Mar;108(1):137-49. doi: 10.1007/s10549-007-9586-8. Epub 2007 Jun 23. Breast Cancer Res Treat. 2008. PMID: 17588204
The CYP1B1_1358_GG genotype is associated with estrogen receptor-negative breast cancer.
Justenhoven C, Pierl CB, Haas S, Fischer HP, Baisch C, Hamann U, Harth V, Pesch B, Brüning T, Vollmert C, Illig T, Dippon J, Ko YD, Brauch H. Justenhoven C, et al. Among authors: pierl cb. Breast Cancer Res Treat. 2008 Sep;111(1):171-7. doi: 10.1007/s10549-007-9762-x. Epub 2007 Oct 6. Breast Cancer Res Treat. 2008. PMID: 17922187
CYP2C19*17 is associated with decreased breast cancer risk.
Justenhoven C, Hamann U, Pierl CB, Baisch C, Harth V, Rabstein S, Spickenheuer A, Pesch B, Brüning T, Winter S, Ko YD, Brauch H. Justenhoven C, et al. Among authors: pierl cb. Breast Cancer Res Treat. 2009 May;115(2):391-6. doi: 10.1007/s10549-008-0076-4. Epub 2008 Jun 3. Breast Cancer Res Treat. 2009. PMID: 18521743
Polymorphisms in the UBC9 and PIAS3 genes of the SUMO-conjugating system and breast cancer risk.
Dünnebier T, Bermejo JL, Haas S, Fischer HP, Pierl CB, Justenhoven C, Brauch H, Baisch C, Gilbert M, Harth V, Spickenheuer A, Rabstein S, Pesch B, Brüning T, Ko YD, Hamann U. Dünnebier T, et al. Among authors: pierl cb. Breast Cancer Res Treat. 2010 May;121(1):185-94. doi: 10.1007/s10549-009-0530-y. Epub 2009 Sep 17. Breast Cancer Res Treat. 2010. PMID: 19760037
One-carbon metabolism and breast cancer risk: no association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany.
Justenhoven C, Hamann U, Pierl CB, Rabstein S, Pesch B, Harth V, Baisch C, Vollmert C, Illig T, Brüning T, Ko Y, Brauch H. Justenhoven C, et al. Among authors: pierl cb. Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):3015-8. doi: 10.1158/1055-9965.EPI-05-0592. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16365030 No abstract available.
Night work and breast cancer estrogen receptor status--results from the German GENICA study.
Rabstein S, Harth V, Pesch B, Pallapies D, Lotz A, Justenhoven C, Baisch C, Schiffermann M, Haas S, Fischer HP, Heinze E, Pierl C, Brauch H, Hamann U, Ko Y, Brüning T; GENICA Consortium. Rabstein S, et al. Scand J Work Environ Health. 2013 Sep 1;39(5):448-55. doi: 10.5271/sjweh.3360. Epub 2013 Mar 29. Scand J Work Environ Health. 2013. PMID: 23543199 Free article.
18 results